Raricap FCM 50MG Injection (10ml) is a specialized medical formulation containing Ferric Carboxymaltose, a complex of iron that is used primarily for the treatment of iron deficiency anemia. Each 10ml vial of Raricap FCM contains 50mg of Ferric Carboxymaltose, which is designed to replenish iron stores in the body effectively and safely. This injectable solution is particularly beneficial for patients who cannot tolerate oral iron supplements or have conditions that require rapid iron replenishment, such as chronic kidney disease, inflammatory bowel disease, or heavy menstrual bleeding. The composition of Raricap FCM allows for a high dose of iron to be administered in a single session, making it a convenient option for patients needing immediate treatment. The drug is administered intravenously, ensuring that the iron is delivered directly into the bloodstream, which enhances its bioavailability and effectiveness. Overall, Raricap FCM 50MG Injection is a vital therapeutic option for managing iron deficiency anemia, helping to improve patients’ quality of life and overall health.